文献速递其他结缔组织病

在系统性硬化症相关间质性肺病大型队列中评估MUC5B启动子变异

Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.
PubMed 文献 · RMD Open · 2025-08-12

在10个欧洲血统队列(2363例SSc-ILD、3526例无ILD的SSc患者、15076例对照)中行Meta分析,rs35705950与SSc-ILD无显著关联(SSc有vs无ILD:P=0.588,OR=1.05,95%CI 0.87~1.27;SSc-ILD vs对照:P=0.061,OR=1.16,95%CI 0.99~1.36),903个额外变异均未达统计学显著。

要点

  • rs35705950与SSc-ILD无显著关联(SSc有vs无ILD:P=0.588,OR=1.05,95%CI 0.87~1.27)。
  • SSc-ILD vs对照亦无显著关联(P=0.061,OR=1.16,95%CI 0.99~1.36)。
  • 100 Kb区域内903个额外变异均未达统计学显著。

核心结论

  • 在迄今最大、统计效能最高的SSc-ILD队列中,未发现MUC5B启动子变异rs35705950及其周围SNP与SSc-ILD存在关联证据。
  • 作者认为SSc-ILD的致病机制可能仅与其他类似ILD(如IPF或RA-ILD)部分重叠,并强调需进一步研究其遗传架构。

研究设计与样本

  • 样本取自血液/唾液,提取DNA后用SNP芯片基因分型,并通过基因组填补获得rs35705950及100 Kb内903个变异的基因型数据。
  • 行Meta分析以增加结果一致性,纳入10个欧洲血统队列,含2363例SSc-ILD患者、3526例无ILD的SSc患者和15076例对照。

主要发现

  • Meta分析显示rs35705950与SSc-ILD无显著关联:SSc有ILD vs无ILD的P=0.588,OR=1.05,95%CI 0.87~1.27。
  • SSc-ILD vs对照的P=0.061,OR=1.16,95%CI 0.99~1.36,未达统计学显著。
  • 该基因组区域内额外检测的903个变异均未达统计学显著。

局限性

  • 作者在结论中强调需进一步研究SSc-ILD的遗传架构。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The common gain-of-function variant rs35705950, located in the promoter of MUC5B gene, has been strongly associated with interstitial lung diseases (ILDs) of different aetiology, such as idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis-associated ILD (RA-ILD). In this study, we aimed to investigate the association of this variant and its nearby single nucleotide polymorphisms (SNPs) in the largest cohort of systemic sclerosis-associated ILD (SSc-ILD) to date. METHODS: Samples were collected from blood/saliva, followed by DNA extraction and genotyping using SNP arrays. Data for rs35705950 and additional 903 variants within 100 Kb were obtained using genomic imputation. Subsequently, we tested their association in a meta-analysis to increase the consistency of the results, including 10 European ancestry cohorts comprising 2363 patients with SSc-ILD, 3526 SSc patients without ILD and 15 076 controls. RESULTS: Meta-analysis showed no significant association between rs35705950 and SSc-ILD, either comparing patients with SSc with and without ILD (p value: 0.588, OR: 1.05, 95% CI: 0.87 to 1.27) nor patients with SSc-ILD with controls (p value: 0.061, OR: 1.16, 95% CI: 0.99 to 1.36). Moreover, none of the additional 903 variants tested in the genomic region reached statistical significance. CONCLUSION: Despite analysing the largest and most statistically powered SSc-ILD cohort to date, we found no evidence of association between the MUC5B promoter variant rs35705950 and its surrounding SNPs with SSc-ILD. These results suggest that the pathogenic mechanisms underlying SSc-ILD may only partially overlap with those of other similar ILDs, such as IPF or RA-ILD. This highlights the need for further studies regarding their genetic architecture.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Rosa-Baez C, Rangel-Pelaez C, Rodriguez-Martin I, et al. Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease. RMD Open. 2025. PMID: 40803819. doi:10.1136/rmdopen-2025-005754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。